The Motley Fool Previous Page

Balchem Earnings Preview

Motley Fool Staff
February 22, 2012

Watch Balchem's (Nasdaq: BCPC  ) earnings report to see if it can beat analyst expectations for the fifth consecutive quarter. The company will unveil its latest earnings on Monday, Feb. 27. Balchem is engaged in the development, manufacture, and marketing of performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries.

What analysts say:

  • Buy, sell, or hold?: Analysts are split on Balchem, as equal numbers rate the stock a buy, sell, and hold. Analysts don't like Balchem as much as competitor Innophos overall. Two out of three analysts rate Innophos a buy compared to one of three for Balchem. Analysts haven't adjusted their rating of Balchem for the past three months.
  • Revenue forec